R. Danny Huntington

Enzo Therapeutics, Inc. v. Yeda Research & Dev. Co. (Eastern District of Virginia) - represented Yeda Research and Development Co. in a §146 Action involving interferon- 2.

N2IT Holding BV v. Native Instruments GmbH (Central District of California) - represented the patent owner N2IT in a patent infringement case concerning electronic systems for controlling the playback of digital music.

Ceravision, Limited V. Luxim Corporation (Northern District of California) - represented Ceravision in a §146 Action involving high-intensity light sources.

Yu et al (Human Genome Sciences, Inc.) v. Browning et al (Biogen Idec) - Interference No. 105,485 - Represented Human Genome Sciences in an interference proceeding relating to LymphoStat-B, a human monoclonal antibody that inhibits the biological activity of B-lymphocyte stimulator (BLyS), before the U.S. Patent and Trademark Office Board of Patent Appeals and Interferences.

Novozymes North America, Inc. v. Genencor International, Inc. - Patent Interference No. 105,155 - Represented Genencor in an interference proceeding relating to cellulase enzymes for detergents before the U.S. Patent and Trademark Office Board of Patent Appeals and Interferences.

Novo Nordisk A/S v. Eli Lilly and Co. (District of Delaware) - represented Lilly in a declaratory judgment action by a competitor for non-infringement and invalidity of Lilly's patent on the rapid-acting human insulin analog formulation, insulin lispro [rDNA origin]), and the product Humalog®.

Eli Lilly and Company v. University of Washington - Represented Eli Lilly in an interference proceeding involving Protein C before the U.S. Patent and Trademark Office Board of Patent Appeals and Interferences.

BASF Corp. v. Eastman Chemical Co. (District of Delaware) - defended Eastman against charge of patent infringement concerning a catalytic process for making 2,5-dihydrofuran, a chemical intermediate.

Novo Nordisk of North America v. Eli Lilly and Company (District of New Jersey) - Defended Lilly against charge of patent infringement case involving Lilly's recombinant human growth hormone (rhGH) and its product Humatrope®.

TV Interactive Data Corporation v. Microsoft Corporation (Northern District of California) - Defended Microsoft against charge of patent infringement involving its Windows technology.

Sturman Industries v. Caterpillar - Represented Sturman in an interference proceeding involving fuel injector valves before U.S. Patent and Trademark Office Board of Patent Appeals and Interferences.

Short v. Patten, Interference No. 105,532 (methods and compositions for polypeptide engineering), United States Patent and Trademark Office, Board of Patent Appeals and Interferences

Howell v. Lentz, Interference No. 105,413 (methods of enhancing immune responses by removing sTNFR1), United States Patent and Trademark Office, Board of Patent Appeals and Interferences

DeLucas (Fluidigm Corp.) v. Santarsiero (Takeda San Diego) - Interference No. 105,403 - Represented Fluidigm Corp. in an interference where the Board of Patent Appeals and Interferences invalidated more than 400 claims from Takeda San Diego's patents.

Sehgal v. Revel, Interference No. 105,304 (interferon β-2, IL-6), United States Patent and Trademark Office, Board of Patent Appeals and Interferences

Sehgal v. Revel, Interference No. 105,303 (interferon β-2, IL-6), United States Patent and Trademark Office, Board of Patent Appeals and Interferences

Sehgal v. Revel, Interference No. 105,302 (interferon β-2, IL-6), United States Patent and Trademark Office, Board of Patent Appeals and Interferences

Sehgal v. Revel, Interference No. 105,293 (interferon β-2, IL-6), United States Patent and Trademark Office, Board of Patent Appeals and Interferences

Short v. Punnonen, Interference No. 105,188 (non-stochastic generation of genetic vaccines), United States Patent and Trademark Office, Board of Patent Appeals and Interferences

Wang v. Murakawa, Interference No. 105,055 (quantitative PCR), United States Patent and Trademark Office, Board of Patent Appeals and Interferences

Deen v. Ni, Interference No. 104,784 (TNF-1), United States Patent and Trademark Office, Board of Patent Appeals and Interferences

Noelle v. Lederman, Interference No. 104,415 (CD40CR monoclonal antibodies), United States Patent and Trademark Office, Board of Patent Appeals and Interferences

Talieh v. Demaray, Interference No. 103,629 (collimated plasma sputtering), United States Patent and Trademark Office, Board of Patent Appeals and Interferences

Dung v. Buehler, Interference No. 105,893 (analgesics), United States Patent and Trademark Office, Patent Trial and Appeal Board

The Best Lawyers in America© in Washington, D.C. (2007-2025)
Ranked in Biotechnology and Life Sciences Practice; Litigation - Intellectual Property; Litigation - Patent; Patent Law
Named 2023 “Lawyer of the Year” in Washington, D.C. for Biotechnology and Life Sciences Practice

Intellectual Asset Management's (IAM) Patent 1000 - The World's Leading Patent Professionals (2013-2024)
Ranked for Prosecution in the D.C. Metro Area; ranked for Post-Grant Proceedings nationwide

Washington, D.C. Super Lawyers (2011-2024)

LMG Life Sciences (2012-2024)
Named a Life Sciences Star

Managing Intellectual Property (MIP) IP Stars (2016-2024)
Ranked as a Patent Star in the District of Columbia and in the U.S. (National)

IAM Strategy 300: The World’s Leading IP Strategists (2013-2019)

Chambers USA (2006-2009; 2012-2018)
Ranked in the area of intellectual property litigation in the District of Columbia

American Bar Association (ABA)

American Intellectual Property Law Association (AIPLA)

District of Columbia Bar Association

Fédération Internationale des Conseils en Propriété Intellectuelle (FICPI)
President of Honour; President, 2006-2009; Vice-President, 2003-2006; Biotechnology Committee, 1988-present